Results 11 to 20 of about 349,122 (350)

Atherogenic dyslipidemia

open access: yesIndian Journal of Endocrinology and Metabolism, 2013
Atherogenic dyslipidemia (AD) refers to elevated levels of triglycerides (TG) and small-dense low-density lipoprotein and low levels of high-density lipoprotein cholesterol (HDL-C).
C N Manjunath   +3 more
doaj   +3 more sources

A novel ultrafast-low-dose computed tomography protocol allows concomitant coronary artery evaluation and lung cancer screening [PDF]

open access: yes, 2018
BACKGROUND:Cardiac computed tomography (CT) is often performed in patients who are at high risk for lung cancer in whom screening is currently recommended.
Bandiera, A   +10 more
core   +1 more source

Editorial: Secondary Dyslipidemias [PDF]

open access: yesThe Open Cardiovascular Medicine Journal, 2011
The term “secondary dyslipidemias” is used to describe the quantitative and/or qualitative alterations in lipoprotein metabolism that complicate the course of other medical disorders. Although the precise prevalence of secondary dyslipidemias has not been determined, the increasing incidence of the conditions that predispose to their development (such ...
Elisaf, M. S., Tsimihodimos, V.
openaire   +3 more sources

Liraglutide downregulates hepatic LDL receptor and PCSK9 expression in HepG2 cells and db/db mice through a HNF-1a dependent mechanism

open access: yesCardiovascular Diabetology, 2018
Background Proprotein convertase subtilisin/kexin type 9 (PCSK9), a major regulator of cholesterol homeostasis, is associated with glucose metabolism. Liraglutide, a glucagon-like peptide-1 receptor agonist, can increase insulin secretion in a glucose ...
Sheng-Hua Yang   +13 more
doaj   +1 more source

Detecting Familial hypercholesterolemia in children and adolescents: potential and challenges

open access: yesItalian Journal of Pediatrics, 2022
Background It is now well established that atherosclerosis begins in childhood and evolves through adolescence and young adulthood, ultimately resulting in myocardial infarction and stroke in adults.
Giuseppe Banderali   +5 more
doaj   +1 more source

Application of expanded genetic analysis in the diagnosis of familial hypercholesterolemia in patients with very early-onset coronary artery disease

open access: yesJournal of Translational Medicine, 2018
Background Patients with monogenic familial hypercholesterolemia (FH) have high risk for coronary artery disease (CAD). A recent FH Expert Panel suggested that FH was underdiagnosed and undertreated which needs early diagnosis.
Ye-Xuan Cao   +12 more
doaj   +1 more source

Persistent hypertriglyceridemia in statin-treated patients with type 2 diabetes mellitus [PDF]

open access: yes, 2013
Purpose: This paper reports the results of an audit that assessed the prevalence of residual hypertriglyceridemia and the potential need for intensified management among patients with statin-treated type 2 diabetes mellitus (T2DM) in primary care in the ...
Feher, Michael D.   +2 more
core   +1 more source

Free fatty acids and cardiovascular outcome: a Chinese cohort study on stable coronary artery disease

open access: yesNutrition & Metabolism, 2017
Background Studies have revealed that plasma level of free fatty acids (FFAs) is related to cardiovascular disease. However, the role of FFAs in clinical outcomes of stable coronary artery disease (SCAD) has been less evaluated.
Hui-Wen Zhang   +8 more
doaj   +1 more source

Oral Porphyromonas gingivalis and Fusobacterium nucleatum Abundance in Subjects in Primary and Secondary Cardiovascular Prevention, with or without Heterozygous Familial Hypercholesterolemia

open access: yesBiomedicines, 2022
Background: Low-grade chronic inflammation, promoted by dysbiosis of the gut and oral microbiota, has been shown to contribute to individual susceptibility to atherosclerotic cardiovascular disease (ASCVD).
Maria Cristina Curia   +10 more
doaj   +1 more source

The association of statin use after cancer diagnosis with survival in pancreatic cancer patients: a SEER-medicare analysis. [PDF]

open access: yes, 2015
BackgroundPancreatic cancer has poor prognosis and existing interventions provide a modest benefit. Statin has anti-cancer properties that might enhance survival in pancreatic cancer patients.
Cook-Wiens, Galen   +6 more
core   +5 more sources

Home - About - Disclaimer - Privacy